ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryEpalingesVandria SA
Vandria SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Vandria SA is a clinical-stage biotech company developing first-in-class small molecules against a novel metabolic target to restore mitochondrial function and reduce chronic inflammation for the treatment of age-related and chronic diseases. Its lead clinical CNS asset, VNA-318, is an orally available, brain-penetrant small molecule that completed Phase I studies demonstrating safety, tolerability and a pharmacokinetic profile suitable for once-daily oral dosing.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Vandria SA

✓ Offered3
Development of small-molecule therapeutics
Development of first-in-class small-molecule therapeutics targeting a novel mechanism to improve mitochondrial function and reduce chronic inflammation in age-related diseases.
Pipeline of NCEs for age-related diseases
Pipeline of novel NCEs for age-related and chronic diseases of the CNS, musculature, lung and liver, including the clinical lead asset VNA-318.
Partnerships and collaborations
Partnerships and collaborations to further develop VNA-318 and to work with a pharma partner for Alzheimer’s and other CNS disorders.
Trust & reputation

ranQ Trust Score of Vandria SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

Vandria SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Vandria SA scores 77.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.64.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Vandria SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Vandria SA scores 43.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.77.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

Vandria SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

December 15, 2023Media
Vandria raises USD 20.6M and emerges from stealth
startupticker.ch

Knowledge

No knowledge articles yet

Once Vandria SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Vandria SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Vandria SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Vandria SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Route de la Corniche 8
1066 Epalinges

At a glance

Legal form
Corporation
UID
CHE-150.318.261
Founded
2021 · 5 years
Last commercial register change
June 12, 2025
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    ES
    Exciva Switzerland SA
    Epalinges
    HT
    Haya Therapeutics SA
    Epalinges
    OT
    Onward Therapeutics SA
    Epalinges
    NB
    ND BioSciences SA
    Epalinges
    LH
    Legacy Healthcare (Switzerland) SA
    Epalinges
    AT
    ADC Therapeutics SA
    Epalinges
    AS
    Asceneuron SA
    Eysins
    AI
    AC Immune SA
    Lausanne